Children's Hospital Boston

A screen of more than 1,120 chemicals in dystrophin-deficient zebrafish revealed three candidates for further testing as treatments for Duchenne or Becker MD

posted on March 24, 2011 - 7:41am
Three small molecules that normalize muscle structure and function and improve survival in dystrophin-deficient zebrafish have been identified by scientists at Children's Hospital Boston, Harvard Medical School, and Alaska Fisheries Science Center in Juneau. The three chemicals, which already are approved for other medical uses, were found to increase survival and normalize muscle structure and...

New content is being added every day. Please check back again.